Skip to main content
. 2017 Dec 5;8(68):112992–113001. doi: 10.18632/oncotarget.22947

Table 1. Clinical data from 85 TCGA patients with primary GBM.

Patient or tumor characteristics Number of patients (%)
Age
 Median 59 years
 Range 18-84 years
Sex
 Male 65 (%)
 Female 35 (%)
Overall survival median (range) 11.7 (0.5 – 90.9) months
Disease-free survival median (range) 6.64 (0.7 – 57.7) months
IDH1 mutation
 Yes 2 (2)
 No 83 (98)